Research Article
Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
Table 5
Multivariate analysis on factors confounding constant and deteriorating oxygen support device.
| | aOR1 | 95% CI | -value |
| Convalescent plasma | 0.45 | 0.12–1.10 | 0.081 | Obesity | 9.18 | 2.0–42.1 | 0.004 | Mechanical ventilation on admission | 0.36 | 0.1–1.27 | 0.113 | Mechanical ventilation during ICU stay | 13.15 | 3.75–46.09 | <0.001 | WBC2 count | 1.71 | 0.69–4.26 | 0.247 | Neutrophil to lymphocyte ratio | 2.5 | 1.07–5.85 | 0.034 | PaO2 to FiO2 ratio | 2.76 | 1.1–6.91 | 0.031 | D-dimer | 1.27 | 0.55–2.90 | 0.573 | Creatinine serum | 1.18 | 0.48–2.93 | 0.709 | Random blood glucose | 1.29 | 0.60–2.78 | 0.519 |
|
|
1Reference group of this regression modeling was patients with constant or deteriorated oxygen device requirements. 2WBC: White blood cells.
|